• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[药物委员会、专业团体及共识会议的决策对医生处方行为的影响]

[Modification of the prescribing practice of the physician by decisions of drug committees, specialty groups and consensus conferences].

作者信息

Müller-Oerlinghausen B

机构信息

Arzneimittelkommission der deutschen Arzteschaft, Köln.

出版信息

Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):606-10.

PMID:9527451
Abstract

The Drug Commission of the Medical Profession influences the prescribing behaviour of physicians operating under the National Health Scheme in various ways with various grades of obligation: 1. via announcements in the journal of the society of physicians of Germany "Deutsches Arzteblatt" with particular focus on aspects of drug safety which the German physician to consider according to the legal opinion has; 2. via the "therapeutic guidelines" according No. 14 of "the guidelines for drug therapy" which the physician operating under the National Health Scheme has to take into account; 3. via a "compendium about drug prescriptions", edited by members of the Drug Commission listing ca. 800 recommended drugs from a total of ca. 2600 individual drugs on the national market: 4. via other means of via other means of communication such as fax-on-demand-service or the bulletin "drug prescription in the medical practice" with contents of significantly less definite character.

摘要

医学职业药品委员会通过各种不同程度的义务方式,影响着在国家健康计划下执业的医生的开药行为:1. 通过在德国医师协会杂志《德国医学周报》上发布公告,特别关注根据法律意见德国医师应考虑的药品安全方面;2. 通过《药物治疗指南》第14号中的“治疗指南”,在国家健康计划下执业的医生必须予以考虑;3. 通过药品委员会成员编辑的一本“药品处方简编”,从全国市场上约2600种单一药品中列出约800种推荐药品;4. 通过其他通信方式,如传真按需服务或“医疗实践中的药品处方”公告,但其内容的确定性明显较低。

相似文献

1
[Modification of the prescribing practice of the physician by decisions of drug committees, specialty groups and consensus conferences].[药物委员会、专业团体及共识会议的决策对医生处方行为的影响]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):606-10.
2
[Modification of the prescribing practice of the physician by drug approval decisions of federal agencies].[联邦机构的药物批准决定对医生处方行为的影响]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):604-6.
3
[Modification of the prescribing practice of the physician by legislation with special reference to non-approved drugs].[通过立法对医生处方行为的规范,特别涉及未经批准的药物]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):610-6.
4
[Approval of drugs by national and European agencies--from the viewpoint of drug approval committee A].
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):600-3.
5
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
6
Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.政策与实践:医疗和教育环境中处方治疗与耐用医疗设备的比较
Pediatrics. 2004 Nov;114(5):e612-25. doi: 10.1542/peds.2004-1063.
7
[Patient education responsibility, specialty and administration information from the viewpoint of the pharmaceutical industry].[从制药行业视角看患者教育责任、专业领域及管理信息]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):649-53.
8
[Special therapeutic processes from the viewpoint of clinical pharmacology].[从临床药理学角度看特殊治疗过程]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):681-5.
9
[Approval of drugs by national and European agencies--sequelae for the pharmaceutical industry].[国家和欧洲机构对药品的批准——制药行业的后遗症]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):596-600.
10
[Experiences of the expert committee on questions of prescribing freedom].[专家委员会关于处方自由问题的经验]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):616-9.